GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC.
FOSTER CITY, CA
Loading...
Price History
Market Data
| Market Cap | 166.36B |
| P/E Ratio | 20.75 |
| P/B Ratio | 7.72 |
| EPS | 6.45 |
| Dividend Yield | 2.36% |
| D/E Ratio | - |
| Current Ratio | 1.45 |
| Currency | USD |
Key Financial Metrics
29.09B
Revenue
8.11B
Net Income
6.45
EPS (Diluted)
13.19B
Free Cash Flow
Profitability
Gross Margin
78.7%
Operating Margin
36.1%
Net Profit Margin
27.9%
EBITDA
10.49B
Returns & Efficiency
Return on Assets (ROA)
13.9%
Return on Equity (ROE)
37.7%
Dividend Yield
2.36%
EPS
6.45
Financial Health
Total Assets
58.53B
Total Debt
24.94B
Debt to Equity
-
Current Ratio
1.45
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Net Value:
-27.95M
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | FOSTER CITY, CA |
| Fiscal Year | 2024 |
Peers
AMGEN INC
AMGN
177.13B
P/E: --
BIOGEN IDEC INC.
BIIB
27.90B
P/E: --
BIOGEN INC.
BIIB
27.90B
P/E: --
19.11B
P/E: --
MODERNA, INC.
MRNA
18.38B
P/E: --
Moderna, Inc.
MRNA
18.38B
P/E: --
13.53B
P/E: 32.5
EXELIXIS, INC.
EXEL
11.29B
P/E: 18.6
Quick Links
Financial Statistics
Valuation
Market Cap$166.36B
P/E Ratio (TTM)20.8
Price to Book7.72
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin78.7%
Operating Margin36.1%
Net Margin27.9%
ROE37.7%
ROA13.9%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.45
Total Debt$24.94B
Total Assets$58.53B
Stockholders' Equity$21.54B
Income Statement (FY 2024)
Revenue$29.09B
Gross Profit$22.90B
Operating Income$10.49B
Net Income$8.11B
EPS (Diluted)$6.45
Cash Flow (FY 2024)
Free Cash Flow$13.19B
Cash & Equivalents-
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 333 LAKESIDE DR FOSTER CITY, CA 94404 |
| Phone | 6505743000 |
| Incorporated | DE, US |
| EIN | 943047598 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.24B |
| Stockholders' Equity | $21.54B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-29
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-28
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-04-28
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-28
Local
SC TO-T/A
SC TO-T/A Filing
SEC regulatory filing
Filed: 2026-04-28
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | GILEAD SCIENCES, INC. |
| Ticker | GILD |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | FOSTER CITY, CA |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 166.36B |
| Revenue | 29.09B |
| Net Income | 8.11B |
| P/E Ratio | 20.75 |
| EPS | 6.45 |
| Net Margin | 27.9% |
| ROE | 37.7% |
| Dividend Yield | 2.36% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...